These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
298 related articles for article (PubMed ID: 39000507)
1. TGF-β Modulated Pathways in Colorectal Cancer: New Potential Therapeutic Opportunities. Fasano M; Pirozzi M; Miceli CC; Cocule M; Caraglia M; Boccellino M; Vitale P; De Falco V; Farese S; Zotta A; Ciardiello F; Addeo R Int J Mol Sci; 2024 Jul; 25(13):. PubMed ID: 39000507 [TBL] [Abstract][Full Text] [Related]
2. OLFM2 promotes epithelial-mesenchymal transition, migration, and invasion in colorectal cancer through the TGF-β/Smad signaling pathway. Tang Y; Liu Y; Wang X; Guo H; Chen L; Hu G; Cui Y; Liang S; Zuo J; Luo Z; Chen X; Wang X BMC Cancer; 2024 Feb; 24(1):204. PubMed ID: 38350902 [TBL] [Abstract][Full Text] [Related]
3. A Novel TGF-β-Related Signature for Predicting Prognosis, Tumor Microenvironment, and Therapeutic Response in Colorectal Cancer. Tao B; Yi C; Ma Y; Li Y; Zhang B; Geng Y; Chen Z; Ma X; Chen J Biochem Genet; 2024 Aug; 62(4):2999-3029. PubMed ID: 38062276 [TBL] [Abstract][Full Text] [Related]
4. TGF-β Signaling in Metastatic Colorectal Cancer (mCRC): From Underlying Mechanism to Potential Applications in Clinical Development. Li X; Wu Y; Tian T Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430910 [TBL] [Abstract][Full Text] [Related]
5. Ginsenoside Rb2 inhibits epithelial-mesenchymal transition of colorectal cancer cells by suppressing TGF-β/Smad signaling. Dai G; Sun B; Gong T; Pan Z; Meng Q; Ju W Phytomedicine; 2019 Mar; 56():126-135. PubMed ID: 30668333 [TBL] [Abstract][Full Text] [Related]
6. LncRNA SNHG6 promotes proliferation, invasion and migration in colorectal cancer cells by activating TGF-β/Smad signaling pathway via targeting UPF1 and inducing EMT via regulation of ZEB1. Wang X; Lai Q; He J; Li Q; Ding J; Lan Z; Gu C; Yan Q; Fang Y; Zhao X; Liu S Int J Med Sci; 2019; 16(1):51-59. PubMed ID: 30662328 [No Abstract] [Full Text] [Related]
7. S100A8 promotes epithelial-mesenchymal transition and metastasis under TGF-β/USF2 axis in colorectal cancer. Li S; Zhang J; Qian S; Wu X; Sun L; Ling T; Jin Y; Li W; Sun L; Lai M; Xu F Cancer Commun (Lond); 2021 Feb; 41(2):154-170. PubMed ID: 33389821 [TBL] [Abstract][Full Text] [Related]
8. Effect of CHRDL1 on angiogenesis and metastasis of colorectal cancer cells via TGF-β/VEGF pathway. Li J; Jiang Z; He J; Yang K; Chen J; Deng Q; Li X; Wu F; Xu S; Jiang Z Mol Carcinog; 2024 Jun; 63(6):1092-1105. PubMed ID: 38415870 [TBL] [Abstract][Full Text] [Related]
9. The long noncoding RNA TUG1 is required for TGF-β/TWIST1/EMT-mediated metastasis in colorectal cancer cells. Shen X; Hu X; Mao J; Wu Y; Liu H; Shen J; Yu J; Chen W Cell Death Dis; 2020 Jan; 11(1):65. PubMed ID: 31988275 [TBL] [Abstract][Full Text] [Related]
10. RUNX1 regulates TGF-β induced migration and EMT in colorectal cancer. Lu C; Yang Z; Yu D; Lin J; Cai W Pathol Res Pract; 2020 Nov; 216(11):153142. PubMed ID: 32866710 [TBL] [Abstract][Full Text] [Related]
11. B4GALT1-dependent galectin-8 binding with TGF-β receptor suppresses colorectal cancer progression and metastasis. Hsu TH; Chang YC; Lee YY; Chen CL; Hsiao M; Lin FR; Chen LH; Lin CH; Angata T; Liu FT; Lin KI Cell Death Dis; 2024 Sep; 15(9):654. PubMed ID: 39231945 [TBL] [Abstract][Full Text] [Related]
12. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression. Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904 [TBL] [Abstract][Full Text] [Related]
13. Regulation of transforming growth factor-β signaling as a therapeutic approach to treating colorectal cancer. Maslankova J; Vecurkovska I; Rabajdova M; Katuchova J; Kicka M; Gayova M; Katuch V World J Gastroenterol; 2022 Sep; 28(33):4744-4761. PubMed ID: 36156927 [TBL] [Abstract][Full Text] [Related]
14. Transforming Growth Factor-β Signaling Pathway in Colorectal Cancer and Its Tumor Microenvironment. Itatani Y; Kawada K; Sakai Y Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31756952 [TBL] [Abstract][Full Text] [Related]
15. MEGF6 Promotes the Epithelial-to-Mesenchymal Transition via the TGFβ/SMAD Signaling Pathway in Colorectal Cancer Metastasis. Hu H; Wang M; Wang H; Liu Z; Guan X; Yang R; Huang R; Tang Q; Zou C; Wang G; Gao X; Wang X Cell Physiol Biochem; 2018; 46(5):1895-1906. PubMed ID: 29719292 [TBL] [Abstract][Full Text] [Related]
16. Fucosylated TGF-β receptors transduces a signal for epithelial-mesenchymal transition in colorectal cancer cells. Hirakawa M; Takimoto R; Tamura F; Yoshida M; Ono M; Murase K; Sato Y; Osuga T; Sato T; Iyama S; Miyanishi K; Takada K; Hayashi T; Kobune M; Kato J Br J Cancer; 2014 Jan; 110(1):156-63. PubMed ID: 24253505 [TBL] [Abstract][Full Text] [Related]
17. DcR3 induces epithelial-mesenchymal transition through activation of the TGF-β3/SMAD signaling pathway in CRC. Liu YP; Zhu HF; Liu DL; Hu ZY; Li SN; Kan HP; Wang XY; Li ZG Oncotarget; 2016 Nov; 7(47):77306-77318. PubMed ID: 27764793 [TBL] [Abstract][Full Text] [Related]
18. Relationship between Epithelial-to-Mesenchymal Transition and Tumor-Associated Macrophages in Colorectal Liver Metastases. Gazzillo A; Polidoro MA; Soldani C; Franceschini B; Lleo A; Donadon M Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555840 [TBL] [Abstract][Full Text] [Related]
19. PEITC inhibits the invasion and migration of colorectal cancer cells by blocking TGF-β-induced EMT. Xiao J; Zhou N; Li Y; Xiao Y; Chen W; Ye J; Ma T; Zhang Y Biomed Pharmacother; 2020 Oct; 130():110743. PubMed ID: 34321176 [TBL] [Abstract][Full Text] [Related]
20. Role of TGF-β in metastatic colon cancer: it is finally time for targeted therapy. Villalba M; Evans SR; Vidal-Vanaclocha F; Calvo A Cell Tissue Res; 2017 Oct; 370(1):29-39. PubMed ID: 28560691 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]